DAVS

The Dutch Annual Virology Symposium (DAVS) provides a platform for young and established virologists to present their research. Traditionally, the symposium takes place around the first week of March in Amsterdam.

DAVS 2019

In 2019, the DAVS will be held on Friday March 8 and, as were the previous editions, will be situated in the “Openbare Bibliotheek Amsterdam” (OBA).

Call for abstracts
You are kindly invited to submit your abstract for oral presentations by email to virology[at]uu.nl. Please include institute, title, and authors (indicate presenter by underlining) in your abstract (300 words max.). Deadline for submission is January 28, 2019. For more information, please refer to the call for abstracts PDF.  

Registration
You can register for this meeting on the KNAW website. Participation is free of charge, but registration is required.

Location
Openbare Bibliotheek van Amsterdam 
Theaterzaal OBA, zevende etage
Oosterdokskade 143
1011 DL Amsterdam

Program

See below for a list of the presentations, a detailed time schedule can be found as a PDF here.

Inhibition of Chikungunya virus replication by targeting host S-adenosyl-homocysteine hydrolase and viral nonstructural protein 1
Martijn van Hemert | LUMC - Leiden 

Identification of a novel inhibitor of alphavirus entry 
Finny Varghese | Radboudumc - Nijmegen 

Viral factors important for the neurotropism of influenza A viruses 
Jurre Siegers | Erasmus MC - Rotterdam 

The Epstein-Barr virus BART18 microRNA directly targets host genes to affect autophagy in infected cells 
Hendrik de Buhr | UMCU - Utrecht 

The transcriptional complexity of varicella-zoster virus unraveled by direct RNA nanopore sequencing 
Shirley Braspenning | Erasmus MC - Rotterdam 

Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group M consensus sequence 
Kwinten Sliepen | AMC-UvA - Amsterdam 

Bispecific single-domain antibody-based complexes protect against bunyavirus infections 
Paul Wichgers Schreur | WUR - Wageningen 

Engineering yellow fever virus 17D–based RNA replicons into an innovative DNA-launched vaccine vector platform for emerging viruses such as MERS-CoV 
Marjolein Kikkert | LUMC – Leiden 

Betacoronavirus S and HE proteins are in functional balance; evidence for convergent evolution of betacorona- and influenzaviruses
Yifei Lang | UU - Utrecht 

Human vaginal and skin dendritic cell subsets control ZIKA virus infection 
Julia Eder | AMC-UvA - Amsterdam 

Zika virus infection perturbs osteoblast function 
Noreen Mumtaz | Erasmus MC - Rotterdam 

Subgenomic flavivirus RNA binds the antiviral mosquito DEAD-box helicase ME31B and determines Zika virus transmission by Aedes aegypti 
Giel Goertz | WUR – Wageningen 

Protective human monoclonal antibodies targeting different stages of MERS coronavirus entry 
Berend Jan Bosch | UU - Utrecht 

Beijerinck Premium Lectures 

Illuminating influenza A virus receptor interactions 
Robert de Vries | Department of Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht

Measles: not an innocent childhood disease 
Rory de Vries | Department of Viroscience, Erasmus MC, Rotterdam 

Beijerinck Prize Lecture 

The Flavivirus NS1 protein: Unraveling mechanisms of pathogenesis of dengue, Zika, and beyond 
Eva Harris | Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, California, United States